SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

01 Aug 2025 Evaluate
The sales is pegged at Rs. 634.90 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 734.66 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 78.38  millions from Rs. 84.32 millions ,decline by -7.04%.Operating Profit reported a sharp decline to 133.57 millions from 145.54 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 634.90 734.66 -13.58 634.90 734.66 -13.58 2864.66 2851.55 0.46
Other Income 9.46 10.57 -10.50 9.46 10.57 -10.50 47.64 42.62 11.78
PBIDT 133.57 145.54 -8.22 133.57 145.54 -8.22 557.08 516.03 7.95
Interest 9.05 11.26 -19.63 9.05 11.26 -19.63 53.67 50.93 5.38
PBDT 124.52 134.28 -7.27 124.52 134.28 -7.27 503.41 465.10 8.24
Depreciation 21.64 21.23 1.93 21.64 21.23 1.93 85.81 97.78 -12.24
PBT 102.88 113.05 -9.00 102.88 113.05 -9.00 417.60 367.32 13.69
TAX 24.50 28.73 -14.72 24.50 28.73 -14.72 99.18 95.73 3.60
Deferred Tax 6.12 0.02 30500.00 6.12 0.02 30500.00 -13.52 -0.62 2080.65
PAT 78.38 84.32 -7.04 78.38 84.32 -7.04 318.42 271.59 17.24
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 21.04 19.81 6.20 21.04 19.81 6.20 19.45 18.10 7.46

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×